133 related articles for article (PubMed ID: 33685816)
1. High-dose-rate brachytherapy for facial skin cancer: Outcome and toxicity assessment for 71 cases.
Renard S; Salleron J; Py JF; Cuenin M; Buchheit I; Marchesi V; Huger S; Meknaci E; Peiffert D
Brachytherapy; 2021; 20(3):624-630. PubMed ID: 33685816
[TBL] [Abstract][Full Text] [Related]
2. HDR brachytherapy for superficial non-melanoma skin cancers.
Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
[TBL] [Abstract][Full Text] [Related]
3. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
4. Experiences with a new high-dose-rate brachytherapy (HDR-BT) boost technique for T3b prostate cancer.
Rades D; Schwarz R; Todorovic M; Thurmann H; Graefen M; Walz J; Schild SE; Dunst J; Alberti W
Strahlenther Onkol; 2007 Jul; 183(7):398-402. PubMed ID: 17609874
[TBL] [Abstract][Full Text] [Related]
5. Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.
Mohammed N; Kestin L; Ghilezan M; Krauss D; Vicini F; Brabbins D; Gustafson G; Ye H; Martinez A
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):204-12. PubMed ID: 21167653
[TBL] [Abstract][Full Text] [Related]
6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
7. Interstitial high-dose-rate brachytherapy in eyelid cancer.
Mareco V; Bujor L; Abrunhosa-Branquinho AN; Ferreira MR; Ribeiro T; Vasconcelos AL; Ferreira CR; Jorge M
Brachytherapy; 2015; 14(4):554-64. PubMed ID: 25959364
[TBL] [Abstract][Full Text] [Related]
8. Tumor control and cosmetic outcome of weekly iridium-192 high-dose-rate brachytherapy for nonmelanoma skin cancers in the elderly.
Roberson J; Patel R; Slutsky JB; Ryu S; Xu Z; Valentine E
Brachytherapy; 2021; 20(4):818-827. PubMed ID: 33789824
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
Yamazaki H; Masui K; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Kotsuma T; Tanaka E; Otani K; Yoshioka Y; Ogawa K
Radiother Oncol; 2019 Mar; 132():162-170. PubMed ID: 30416045
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate brachytherapy boost for prostate cancer: Comparison of three different fractionation schemes.
Falk AT; Demontoy S; Chamorey E; Chand ME; Gautier M; Azria D; Zaki S; Chevallier D; Cham Kee DL; Hannoun-Lévi JM
Brachytherapy; 2017; 16(5):993-999. PubMed ID: 28754301
[TBL] [Abstract][Full Text] [Related]
11. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer.
Armstrong S; Tsang Y; Lowe G; Tharmalingam H; Alonzi R; Ostler P; Hughes R; Hoskin P
Radiother Oncol; 2021 Apr; 157():93-98. PubMed ID: 33493500
[TBL] [Abstract][Full Text] [Related]
13. Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
Jo Y; Fujii T; Hara R; Yokoyama T; Miyaji Y; Yoden E; Hiratsuka J; Nagai A
BJU Int; 2012 Mar; 109(6):835-9. PubMed ID: 21933327
[TBL] [Abstract][Full Text] [Related]
14. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.
Jiang P; van der Horst C; Kimmig B; Zinsser F; Poppe B; Luetzen U; Juenemann KP; Dunst J; Siebert FA
Brachytherapy; 2017; 16(1):186-192. PubMed ID: 28341011
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of patients with localized and locally advanced prostate cancer undergoing high-dose-rate brachytherapy with external-beam radiotherapy at our institute.
Makino T; Mizokami A; Namiki M
Anticancer Res; 2015 Mar; 35(3):1723-8. PubMed ID: 25750334
[TBL] [Abstract][Full Text] [Related]
16. Nineteen-year single-center experience in 76 patients with penile cancer treated with high-dose-rate brachytherapy.
Kellas-Ślęczka S; Białas B; Fijałkowski M; Wojcieszek P; Szlag M; Cholewka A; Wesołowski M; Ślęczka M; Krzysztofiak T; Larysz D; Kołosza Z; Trzaska K; Pruefer A
Brachytherapy; 2019; 18(4):493-502. PubMed ID: 31101437
[TBL] [Abstract][Full Text] [Related]
17. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
18. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
[TBL] [Abstract][Full Text] [Related]
19. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
20. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]